Drug Trial Radar · NCT04505436
Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
215
Actual
Start
Jul 31, 2020
Primary completion
Jun 26, 2026
Study completion Jul 15, 2026
Sponsor
- Lead sponsor
- Hanmi Pharmaceutical Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- Aug 10, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a phase 2 study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH
Conditions
- NASH - Nonalcoholic Steatohepatitis
Interventions
HM15211Drug
A sterile solution of HM15211 (efocipegtrutide) contained in pre-filled syringes
Placebo of HM15211Drug
A sterile, matching solution in pre-filled syringes
Primary outcomes
What the sponsor says the trial is designed to measure.
- pharmacodynamic (PD) effect of HM15211Time frame: 12 months
Locations
60 sites in 2 countries. Site status is shown where the registry gives one.
North Alabama GI Research Center
Huntsville, Alabama
Synexus US - Chandler
Chandler, Arizona
Precision Research Institute, LLC. (PRI)
Chula Vista, California
Fresno Clinical Research Center
Fresno, California
NAFLD Research Center - Altman Clinical and Translational Research Institute
La Jolla, California
UC Davis Health System - Midtown Ambulatory Care Center
Sacramento, California
University of Florida College of Medicine
Gainesville, Florida
Schiff Center for Liver Diseases - University of Miami Leonard M. Miller School of Medicine(UMMSM)
Miami, Florida
San Marcus Research Clinic
Miami Lakes, Florida
Floridian Clinical Research, LLC
Miami Lakes, Florida
Ocala GI Research
Ocala, Florida
Synexus Clinical Research US, Inc. - Orlando
Orlando, Florida
Synexus Clinical Research US, Inc. - The Villages
The Villages, Florida
Synexus Clinical Research US, Inc
Chicago, Illinois
Gastroenterology Health Partners, PLLC - Southern Indiana
New Albany, Indiana
Kansas Medical Clinic PA (KMC) - Gastrointestinal Medical Plaza
Topeka, Kansas
Tandem Clinical Research, LLC
Marrero, Louisiana
University of Maryland Medical Center
Baltimore, Maryland
Mercy Medical Center - The Institute for Digestive Health and Liver Disease
Baltimore, Maryland
Brigham and Women's hospital
Boston, Massachusetts
Henry Ford Hospital
Detroit, Michigan
West Michigan Clinical Research Center
Wyoming, Michigan
Mayo Clinic Rochester
Rochester, Minnesota
Nevada Family Care & Wellness Center
Henderson, Nevada
Tandem Clinical Research, LLC
New York, New York
UNC Health Care System
Chapel Hill, North Carolina
Carolinas Center for Liver Disease, Carolinas HealthCare System/Atrium Health
Charlotte, North Carolina
Duke University Medical Center
Durham, North Carolina
Lucas Research
Morehead City, North Carolina
Consultants for Clinical Research
Liberty Township, Ohio
University of Pittsburgh Medical Center (UPMC) - The Center for Liver Diseases
Pittsburgh, Pennsylvania
ClinSearch
Chattanooga, Tennessee
Texas Clinical Research Institute, LLC
Arlington, Texas
Texas Liver Institute (TLI) - Texas Metabolic Center
Austin, Texas
The Liver Institute at Methodist Dallas
Dallas, Texas
Dallas Diabetes and Endocrine Center
Dallas, Texas
Liver Center of Texas, PLLC
Dallas, Texas
Synexus Clinical Research US, Inc
Dallas, Texas
Digestive Health Associates of Texas, P.A. (DHAT)
Garland, Texas
Baylor College of Medicine - Advanced Liver Therapies
Houston, Texas
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.